SCHEMBL2344809

SCHEMBL2344809

Cc1ccc(-c2n[c]nc3c2CCN(Cc2ccccc2)C3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.47
GABRA1 P14867 1/20 0.45
GABRA5 P31644 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
CLPP Q16740 2/20 0.44
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
ACHE P22303 2/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
C5AR1 P21730 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183675 0.81 HTR2A (0.64) LMNAPOLBGABRA1GABRA5GABRA3
SCHEMBL2341888 0.79 HTR2A (0.53) LMNAPOLBGABRA1GABRA5GABRA3
SCHEMBL2343194 0.79 ALDH1A1 (0.47) LMNAPOLBGABRA1GABRA5GABRA3
SCHEMBL183618 0.78 P2RX7 (0.53) DRD2DRD4DRD3ALDH1A1MAPT
Hydrochloric Acid SCHEMBL6298078 0.77 P2RX7 (0.52) DRD2DRD4DRD3ALDH1A1MAPT
SCHEMBL2076569 0.74 HTR2A (0.53) LMNAPOLBGABRA1GABRA5GABRA3
SCHEMBL12386805 0.74 P2RX7 (0.50) CLPPALDH1A1MAPTC5AR1KMT2A
SCHEMBL4147065 0.74 C5AR1 (0.57) GABRA1GABRA2CLPPALDH1A1MAPT
SCHEMBL22720571 0.74 KMT2A (0.48) LMNAACHEALDH1A1MAPTC5AR1
SCHEMBL16034465 0.73 KMT2A (0.53) ALDH1A1MAPTC5AR1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829011-B2 2-aminopyrimidine compounds as serotonin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-09-09 US disclosed
US-20110207717-A1 2-AMINOPYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207717-A1 2-AMINOPYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS HTR2A, HTR6, HTR5A LMNA 4702/4885POLB 2239/4885GABRA1 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.